glp 1 receptor agonists beyond their pancreatic effects GLP-1 as Treatments for Type 2 Diabetes The pancreatic and extrapancreatic effect

A patient who begins GLP-1 therapy often experiences significant fatigue, nausea, and reduced appetite in the early weeks

GLP-1RA Mechanism of Action GLP-1 (glucagon-like peptide-1) is a hormone secreted by the intestinal tract during feeding, which enhances insulin secretion and inhibits glucagon secretion in a glucose concentration-dependent manner, and delays gastric emptying to reduce the amount of food eaten through central appetite suppression

Effect of GLP-1 RAs on LDL-C, HDL-C, and TL levels Studies have shown contradictions regarding the effect of GLP-1 RAs on LDL-C levels in the body, specifically with liraglutide or exenatide

The increased risk for cancer associated with obesity is mediated partly by changes in the immune system

It enrolled 17,604 adults aged 45 or older with a body mass index (BMI) of 27 kg/m2 or greater and preexisting CVD (prior MI, prior stroke or peripheral artery disease) without diabetes